HAE
Haemonetics Corporation
NYSE: HAE · HEALTHCARE · MEDICAL DEVICES
$52.67
-5.30% today
Updated 2026-05-06
Market cap
$2.75B
P/E ratio
16.33
P/S ratio
2.09x
EPS (TTM)
$3.63
Dividend yield
—
52W range
$47 – $87
Volume
0.7M
Haemonetics Corporation (HAE) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $546.54M | $572.74M | $608.95M | $649.69M | $754.14M | $833.26M | $910.63M | $1.46B | $1.52B | $1.48B | $1.32B | $1.24B | $1.24B | $1.27B | $1.27B | $1.82B | $1.86B | $1.93B | $2.20B | $2.45B |
| Cash & equivalents | $250.67M | $229.23M | $133.55M | $156.72M | $141.56M | $196.71M | $228.86M | $179.12M | $192.47M | $160.66M | $115.12M | $139.56M | $180.17M | $169.35M | $137.31M | $192.31M | $259.50M | $284.47M | $178.80M | $306.76M |
| Current assets | $418.40M | $403.67M | $359.43M | $382.39M | $373.69M | $448.83M | $526.63M | $596.97M | $629.64M | $567.98M | $487.20M | $510.03M | $521.18M | $576.12M | $603.64M | $693.55M | $756.03M | $769.72M | $768.90M | $934.98M |
| Total liabilities | $104.89M | $93.09M | $114.76M | $109.81M | $161.02M | $147.13M | $175.56M | $692.69M | $681.23M | $657.00M | $597.13M | $499.10M | $484.91M | $606.90M | $680.00M | $1.09B | $1.11B | $1.12B | $1.24B | $1.63B |
| Current liabilities | $88.12M | $82.02M | $97.68M | $92.86M | $131.10M | $108.67M | $130.74M | $179.80M | $217.81M | $189.09M | $184.71M | $211.18M | $384.70M | $235.76M | $274.82M | $253.50M | $442.27M | $251.82M | $300.38M | $578.11M |
| Long-term debt | $12.98M | $6.67M | $6.04M | $5.34M | $4.59M | $3.97M | $2.88M | $456.94M | $392.06M | $406.37M | $364.53M | $253.63M | $59.42M | $322.45M | $305.51M | $690.59M | $559.44M | $754.10M | $797.56M | $921.23M |
| Shareholder equity | $441.65M | $479.65M | $494.19M | $539.88M | $593.12M | $686.14M | $735.08M | $769.18M | $839.61M | $826.12M | $719.98M | $739.61M | $752.43M | $667.87M | $587.11M | $731.67M | $749.42M | $818.00M | $959.96M | $820.84M |
| Retained earnings | $302.85M | $315.77M | $302.20M | $309.52M | $334.64M | $373.63M | $400.78M | $398.20M | $433.35M | $420.37M | $316.18M | $289.92M | $266.94M | $161.42M | $78.51M | $157.98M | $202.39M | $253.17M | $360.46M | $352.17M |
| Accounts receivable | $86.90M | $91.83M | $120.25M | $113.60M | $118.68M | $127.17M | $135.46M | $170.11M | $164.60M | $145.83M | $157.09M | $152.68M | $151.23M | $185.03M | $165.21M | $127.56M | $159.38M | $179.14M | $206.56M | $202.66M |
| Inventory | $54.57M | $61.80M | $65.39M | $76.52M | $79.95M | $84.39M | $117.16M | $183.78M | $197.66M | $211.08M | $186.14M | $176.93M | $160.80M | $194.34M | $270.28M | $322.61M | $293.03M | $259.38M | $317.20M | $365.14M |
| Goodwill | $18.48M | $34.96M | $54.22M | $56.43M | $120.54M | $115.37M | $115.06M | $330.47M | $336.77M | $334.31M | $267.84M | $210.84M | $211.40M | $210.82M | $210.65M | $466.44M | $467.29M | $466.23M | $565.08M | $604.27M |